Derivation of functional ventricular cardiomyocytes using endogenous promoter sequence from murine embryonic stem cells

Stem Cell Research

Volumn 8, Issue 1, 2012, Pages 49-57

  Lee, Min Young ^a   Sun, Baonan ^b   Schliffke, Simon ^a   Yue, Zhichao ^b   Ye, Mingyu ^a,d   Paavola, Jere ^a,c   Bozkulak, Esra Cagavi ^a   Amos, Peter J ^a   Ren, Yongming ^a   Ju, Rong ^a   Jung, Yong Woo ^e   Ge, Xin ^a   Yue, Lixia ^b   Ehrlich, Barbara E ^a   Qyang, Yibing ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c MINERVA FOUNDATION INSTITUTE FOR MEDICAL RESEARCH   (Finland)

^d INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^e Korea University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR; CALCIUM ION; ISOPRENALINE; MYOSIN LIGHT CHAIN 2; NERVE CELL ADHESION MOLECULE; YELLOW FLUORESCENT PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CELL ADHESION; CELL CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; CELL STRUCTURE; CONTROLLED STUDY; ELECTROSTIMULATION; EMBRYOID BODY; EMBRYONIC STEM CELL; EXCITATION CONTRACTION COUPLING; FLUORESCENCE ACTIVATED CELL SORTING; GAP JUNCTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE FIBER MEMBRANE POTENTIAL; IMMUNOCYTOCHEMISTRY; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TISSUE ENGINEERING; VENTRICULAR CARDIOMYOCYTE;

ACTION POTENTIALS; ADHERENS JUNCTIONS; ANIMALS; BACTERIAL PROTEINS; BASE SEQUENCE; CADHERINS; CALCIUM; CELL CULTURE TECHNIQUES; CELL LINE; CELL SEPARATION; CONNEXIN 43; EMBRYONIC STEM CELLS; FLOW CYTOMETRY; GAP JUNCTIONS; HEART VENTRICLES; IMAGING, THREE-DIMENSIONAL; INTEGRASES; LUMINESCENT PROTEINS; MICE; MYOCYTES, CARDIAC; MYOSIN LIGHT CHAINS; PROMOTER REGIONS, GENETIC; PROTEINS;

MURINAE; MUS MUSCULUS;

EID: 80052724445     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2011.08.004     Document Type: Article

References (37)

1. Abou-Khalil R., Le Grand F., Pallafacchina G., et al. Autocrine and paracrine angiopoietin 1/Tie-2 signaling promotes muscle satellite cell self-renewal. Cell Stem Cell 2009, 5:298-309.
2. Chen J., Kubalak S.W., Price S., et al. Selective requirement of myosin light chain 2v in embryonic heart function. J. Biol. Chem. 1998, 273:1252-1256.
3. Evans M.J., Kaufman M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981, 292:154-156.
4. Freude B., Masters T.N., Robicsek F., et al. Apoptosis is initiated by myocardial ischemia and executed during reperfusion. J. Mol. Cell. Cardiol. 2000, 32:197-208.
5. Gepstein L. Cell and gene therapy strategies for the treatment of postmyocardial infarction ventricular arrhythmias. Ann. N. Y. Acad. Sci. 2010, 1188:32-38.
6. Hansson E.M., Lindsay M.E., Chien K.R. Regeneration next: toward heart stem cell therapeutics. Cell Stem Cell 2009, 5:364-377.
7. Hattori F., Chen H., Yamashita H., et al. Nongenetic method for purifying stem cell-derived cardiomyocytes. Nat. Methods 2010, 7:61-66.
8. He J.Q., Ma Y., Lee Y., Thomson J.A., Kamp T.J. Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ. Res. 2003, 93:32-39.
9. Hidaka K., Shirai M., Lee J.K., et al. The cellular prion protein identifies bipotential cardiomyogenic progenitors. Circ. Res. 2010, 106:111-119.
10. Jessup M., Brozena S. Heart failure. N. Engl. J. Med. 2003, 348:2007-2018.
11. Kehat I., Kenyagin-Karsenti D., et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J. Clin. Invest. 2001, 108:407-414.
12. Kita-Matsuo H., Barcova M., Prigozhina N., et al. Lentiviral vectors and protocols for creation of stable hESC lines for fluorescent tracking and drug resistance selection of cardiomyocytes. PLoS One 2009, 4:e5046.
13. Klug M.G., Soonpaa M.H., Koh G.Y., Field L.J. Genetically selected cardiomyocytes from differentiating embronic stem cells from stable intracardiac grafts. J. Clin. Invest. 1996, 98:216-224.
14. Kolossov E., Fleischmann B.K., Liu Q. Functional characteristics of ES cell-derived cardiac precursor cells identified by tissue-specific expression of the green fluorescent protein. J. Cell Biol. 1998, 143:2045-2056.
15. Laflamme M.A., Chen K.Y., Naumova A.V., et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol. 2007, 25:1015-1024.
16. Maltsev V.A., Wobus A.M., Rohwedel J., Bader M., Hescheler J. Cardiomyocytes differentiated in vitro from embryonic stem cells developmentally express cardiac-specific genes and ionic currents. Circ. Res. 1994, 75:233-244.
17. Minamisawa S., Gu Y., Ross J., Chien K.R., Chen J. Post-transcriptional compensatory pathway in heterozygous ventricular myosin light chain 2-deficient mice results in lack of gene dosage effect during normal cardiac growth or hypertrophy. J. Biol. Chem. 1999, 274:10066-10070.
18. Moore J.C., Spijker R., Martens A.C., et al. A P19Cl6 GFP reporter line to quantify cardiomyocyte differentiation of stem cells. Int. J. Dev. Biol. 2004, 48:47-55.
19. Moore J.C., Fu J., Chan Y.C., et al. Distinct cardiogenic preferences of two human embryonic stem cell (hESC) lines are imprinted in their proteomes in the pluripotent state. Biochem. Biophys. Res. Commun. 2008, 372:553-558.
20. Müller M., Fleischmann B.K., Selbert S., et al. Selection of ventricular-like cardiomyocytes from ES cells in vitro. FASEB J. 2000, 14:2540-2548.
21. Müller-Ehmsen J., Peterson K.L., et al. Rebuilding a damaged heart: long-term survival of transplanted neonatal rat cardiomyocytes after myocardial infarction and effect on cardiac function. Circulation 2002, 105:1720-1726.
22. Mummery C., Ward-van Oostwaard D., Eoevendans P., et al. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation 2003, 107:2733-2740.
23. Noorman M., van der Heyden M.A., van Veen T.A., et al. Cardiac cell-cell junctions in health and disease: Electrical versus mechanical coupling. J. Mol. Cell. Cardiol. 2009, 47:23-31.
24. 2+ sensitivity of force and activation dependence of the kinetics of myocardial force development. Am. J. Physiol. Heart Circ. Physiol. 2004, 287:H2712-H2718.
25. Qyang Y., Martin-Puig S., Chiravuri M., et al. The renewal and differentiation of Isl1+ cardiovascular progenitors are controlled by a Wnt/beta-catenin pathway. Cell Stem Cell 2007, 1:165-179.
26. Reinecke H., Minami E., Zhu W.Z., Laflamme M.A. Cardiogenic differentiation and transdifferentiation of progenitor cells. Circ. Res. 2008, 103:1058-1071.
27. Roell W., Lu Z.J., Bloch W., et al. Cellular cardiomyoplasty improves survival after myocardial injury. Circulation 2002, 105:2435-2441.
28. Scarabelli T., Stephanou A., Rayment N., et al. Apoptosis of endothelial cells precedes myocyte cell apoptosis in ischemia/reperfusion injury. Circulation 2001, 104:253-256.
29. Thom T., Haase N., Rosamond W., et al. Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006, 113:e85-e151.
30. van Laake L.W., Passier R., Monshouwer-Kloots J., et al. Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. Stem Cell Res. 2007, 1:9-24.
31. Wang L.J., Sobie E.A. Mathematical model of the neonatal mouse ventricular action potential. Am. J. Physiol. Heart Circ. Physiol. 2008, 294:H2565-H2575.
32. Wobus A.M., Kaomei G., Shan J., et al. Retinoic acid accelerates embryonic stem cell-derived cardiac differentiation and enhances development of ventricular cardiomyocytes. J. Mol. Cell. Cardiol. 1997, 29:1525-1539.
33. Xu C., Police S., Rao N., Carpenter M.K. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ. Res. 2002, 91:501-508.
34. + embryonic-stem-cell-derived population. Nature 2008, 453:524-528.
35. Zandstra P.W., Bauwens C., Yin T., et al. Scalable production of embryonic stem cell-derived cardiomyocytes. Tissue Eng. 2003, 9:767-778.
36. Zhang J., Wilson G.F., Soerens A.G., et al. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ. Res. 2009, 104:e30-e41.
37. Zhu W.Z., Xie Y., Moyes K.W., Gold J.D., Askari B., Laflamme M.A. Neuregulin/ErbB signaling regulates cardiac subtype specification in differentiating human embryonic stem cells. Circ. Res. 2010, 107:776-786.